Alignment Healthcare (ALHC) Shares Outstanding (Weighted Average) (2020 - 2026)

Alignment Healthcare has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $205.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 6.07% year-over-year to $205.4 million; the trailing twelve-month figure through Mar 2026 stood at $205.4 million (up 6.07% YoY), and the FY2025 full-year result was $198.0 million, up 3.78% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $205.4 million, up from $198.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $205.4 million in Q1 2026, with the low at $180.1 million in Q2 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $190.2 million across 5 years, with a median of $189.0 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) increased 12.97% — and 2023, when it decreased 2.13%.
• Alignment Healthcare's Shares Outstanding (Weighted Average) stood at $181.2 million in 2022, then gained by 2.76% to $186.2 million in 2023, then rose by 2.46% to $190.8 million in 2024, then rose by 3.78% to $198.0 million in 2025, then increased by 3.71% to $205.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $205.4 million (Q1 2026), $198.0 million (Q4 2025), and $199.0 million (Q3 2025), per Business Quant data.